Donald Taylor
My research interests include chronic wound healing. We’re investigating the unique properties of mesenchymal stem cells (MSCs) embedded within a two part polyethylene glycol and dihydroxyphenyl-L-alanine polymer infused with covalently tethered matrikines that will support defined MSC survival and engraftment efficiency before the therapeutic MSCs expire. This biocompatible and biodegradable wound gel thus serves as a cell-based therapy and delivery device enabling wound healing where other interventions fail to stem infection risk, initiate angiogenesis, and/or recruit stromal support cells to fully resolve the wound healing process. I believe that our proposed cell-based polymeric wound gel with a functional biomaterial-based niche for cell delivery and antimicrobial properties will revolutionize therapeutic approaches, save lives, improve quality of life and reduce high costs associated with treating chronic and traumatic wounds. I am also focused on a hybrid academic & translational CEO career whereby I will leverage my global life sciences commercial experience with my research training in order to: 1) advance the most promising university technologies to commercialization, 2) establish academic/industry partnerships, and 3) help train the next generation of world-class translational development scientific entrepreneurs.